Anhui Fengyuan Pharmaceutical Co Ltd (000153) — Capital Reinvestment Ratio
Anhui Fengyuan Pharmaceutical Co Ltd (000153) has a Capital Reinvestment Ratio of 0.46x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥69.15 Million) in capital expenditures (CN¥32.02 Million). See Anhui Fengyuan Pharmaceutical Co Ltd (000153) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Anhui Fengyuan Pharmaceutical Co Ltd Capital Reinvestment Ratio (1999–2025)
This chart tracks Anhui Fengyuan Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 24 annual periods. Check 000153 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Anhui Fengyuan Pharmaceutical Co Ltd (1999–2025)
Year-by-year Capital Reinvestment Ratio for Anhui Fengyuan Pharmaceutical Co Ltd from 1999 to 2025. For live market cap and broader valuation context, see Anhui Fengyuan Pharmaceutical Co Ltd (000153) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.85x | CN¥119.30 Million | CN¥220.61 Million | ▲ +62.1% |
| 2024 | 1.14x | CN¥126.24 Million | CN¥144.02 Million | ▲ +91.1% |
| 2023 | 0.60x | CN¥254.75 Million | CN¥152.12 Million | ▲ +221.3% |
| 2022 | 0.19x | CN¥439.99 Million | CN¥81.76 Million | ▼ -71.9% |
| 2021 | 0.66x | CN¥237.88 Million | CN¥157.36 Million | ▲ +1.5% |
| 2020 | 0.65x | CN¥292.75 Million | CN¥190.74 Million | ▼ -70.4% |
| 2019 | 2.20x | CN¥66.21 Million | CN¥145.62 Million | ▲ +507.0% |
| 2018 | 0.36x | CN¥233.59 Million | CN¥84.63 Million | ▼ -60.4% |
| 2017 | 0.92x | CN¥52.40 Million | CN¥47.99 Million | ▲ +223.2% |
| 2016 | 0.28x | CN¥78.21 Million | CN¥22.17 Million | ▼ -74.4% |
| 2015 | 1.11x | CN¥45.50 Million | CN¥50.33 Million | ▼ -93.4% |
| 2014 | 16.73x | CN¥10.51 Million | CN¥175.86 Million | ▲ +703.5% |
| 2012 | 2.08x | CN¥45.65 Million | CN¥95.06 Million | ▲ +64.1% |
| 2011 | 1.27x | CN¥55.06 Million | CN¥69.86 Million | ▼ -22.2% |
| 2010 | 1.63x | CN¥55.04 Million | CN¥89.75 Million | ▼ -29.0% |
| 2009 | 2.30x | CN¥32.41 Million | CN¥74.42 Million | ▲ +262.3% |
| 2008 | 0.63x | CN¥49.82 Million | CN¥31.58 Million | ▼ -0.4% |
| 2007 | 0.64x | CN¥55.26 Million | CN¥35.18 Million | ▼ -83.1% |
| 2006 | 3.77x | CN¥36.27 Million | CN¥136.67 Million | ▲ +268.4% |
| 2005 | 1.02x | CN¥34.88 Million | CN¥35.68 Million | ▼ -88.3% |
| 2002 | 8.73x | CN¥10.48 Million | CN¥91.40 Million | ▲ +8.1% |
| 2001 | 8.07x | CN¥23.57 Million | CN¥190.24 Million | ▲ +77.3% |
| 2000 | 4.55x | CN¥25.88 Million | CN¥117.82 Million | ▲ +0.5% |
| 1999 | 4.53x | CN¥1.01 Million | CN¥4.59 Million | — |